Drug General Information (ID: DDI6QCY1BS)
Drug Name			Enoxacin		Drug Info		Mefenamic acid		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Antiinfective Agents				Antiinflammatory Agents
Structure

Mechanism of Enoxacin-Mefenamic acid Interaction (Severity Level: Moderate)
Additive CNS stimulant effects Click to Show/Hide Mechanism Graph
Drug Name		Enoxacin				Mefenamic acid
Mechanism		CNS stimulant effects				CNS stimulant effects
Key Mechanism Factor 1
		Factor Name		CNS stimulant effects
		Factor Description		CNS stimulants are drugs that stimulate the brain and can speed up mental and physical processes. Excessive CNS stimulation may lead to decreased appetite, increased heart rate, increased blood pressure, increased body temperature, convulsions, and seizures.
Mechanism Description		Additive CNS stimulant effects by the combination of Enoxacin and Mefenamic acid

Recommended Action
Management		Clinical monitoring for signs of CNS stimulation such as tremors, involuntary muscle movements, hallucinations, or seizures is recommended if fluoroquinolone antibiotics are prescribed in combination with NSAIDs.

References
1	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
2	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
3	Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
4	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
5	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
6	Product Information. Penetrex (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA.
7	Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
8	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
9	Ball P, Tillotson G "Tolerability of fluoroquinolone antibiotics: past, present and future." Drug Saf 13 (1996): 343-8. [PMID: 8652079]
10	Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
11	Domagala JM "Structure-activity and structure-side-effect relationships for the quinolone antibacterials." J Antimicrob Chemother 33 (1994): 685-706. [PMID: 8056688]
12	Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
13	Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
14	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.